Derek Dirocco serves as Executive at Mineralys Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Derek Dirocco has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2026 involved receiving (via award) 8,300 shares valued at $0.
Derek Dirocco currently holds 8,300 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Derek Dirocco has been a net neutral trader of MLYS stock. They have purchased $0 and sold $0 worth of shares.
Derek Dirocco's most recent insider trade was on Feb 19, 2026, when they sold 8,300 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |